Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Iloprost for additional anticoagulation in continuous renal replacement therapy - a pilot study.

Iloprost for additional anticoagulation in continuous renal replacement therapy - a pilot study. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Iloprost for additional anticoagulation in continuous renal replacement therapy - a pilot study. Abstract Text:

     birnbaum Birnbaum,claudia d spiesClaudia D Spies,edda klotzEdda Klotz,ortrud vargas heinOrtrud Vargas Hein,stanislao morgeraStanislao Morgera,tania schinkTania Schink,sabine ziemerSabine Ziemer,mona s grundMona S Grund, saalmann Saalmann,wolfgang j koxWolfgang J Kox,christian lehmannChristian Lehmann, birnbaum Birnbaum,claudia d spiesClaudia D Spies,edda klotzEdda Klotz,ortrud vargas heinOrtrud Vargas Hein,stanislao morgeraStanislao Morgera,tania schinkTania Schink,sabine ziemerSabine Ziemer,mona s grundMona S Grund, saalmann Saalmann,wolfgang j koxWolfgang J Kox,christian lehmannChristian Lehmann,

    PURPOSE: The aim of this pilot study was to compare the effect of heparin anticoagulation with and without iloprost administration during continuous renal replacement therapy (CRRT) in critically ill patients. MATERIAL AND METHODS: In a prospective, randomized, controlled pilot study at an intensive care unit at a university hospital, 20 patients requiring CRRT were investigated. Patients were allocated into two groups: group 1, the heparin group; and group 2, the heparin plus 1 ng/kg/min iloprost. In both groups, activated partial thromboplastin time (aPTT) was adjusted to 40-50 sec. Observation time was a maximum of 7 days. RESULTS: Median filter run time was significantly prolonged by iloprost administration to a median of 14 h (13-26 h) compared to 10 h (4-12 h) in the heparin group (p = 0.004). A decrease in platelet count was attenuated by iloprost administration (p = 0.012). There were no bleeding complications in either group. Hemofiltration efficiency did not differ significantly between the groups. CONCLUSION: Additional administration of iloprost prolonged the filter run time of continuous veno-venous hemofiltration (CVVH) in this setting and attenuated the fall in platelet count during CRRT.

    Iloprost for additional anticoagulation in continuous renal replacement therapy - a pilot study. Publishing Authors By Initials

    j birnbaumJ Birnbaum,cd spiesCD Spies,e klotzE Klotz,ov heinOV Hein,s morgeraS Morgera,t schinkT Schink,s ziemerS Ziemer,ms grundMS Grund,r saalmannR Saalmann,wj koxWJ Kox,c lehmannC Lehmann,j birnbaumJ Birnbaum,cd spiesCD Spies,e klotzE Klotz,ov heinOV Hein,s morgeraS Morgera,t schinkT Schink,s ziemerS Ziemer,ms grundMS Grund,r saalmannR Saalmann,wj koxWJ Kox,c lehmannC Lehmann,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Iloprost for additional anticoagulation in continuous renal replacement therapy - a pilot study. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Renal failure

    VOLUME: 29

    Page Numbers: 271-7

    Journal Abbreviation:

    ISSN: 0886-022X

    DAY: 14

    MONTH: 05

    YEAR: 2007

    Iloprost for additional anticoagulation in continuous renal replacement therapy - a pilot study. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8701128

    Iloprost for additional anticoagulation in continuous renal replacement therapy - a pilot study. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Iloprost for additional anticoagulation in continuous renal replacement therapy - a pilot study. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Iloprost for additional anticoagulation in continuous renal replacement therapy - a pilot study.

    AFFILIATION: Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Charité Virchow-Klinikum, Charité-University Medicine, Berlin, Germany. juergen.birnbaum@charite.de

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Ren Fail

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Iloprost for additional anticoagulation in continuous renal replacement therapy - a pilot study Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News